Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Pactiv Evergreen Q3 2024 Adj. EPS $0.36, Inline, Sales $1.333B Miss $1.374B Estimate

Author: Benzinga Newsdesk | November 12, 2024 07:08am
Pactiv Evergreen (NASDAQ:PTVE) reported quarterly earnings of $0.36 per share which met the analyst consensus estimate. The company reported quarterly sales of $1.333 billion which missed the analyst consensus estimate of $1.374 billion by 2.95 percent. This is a 3.34 percent decrease over sales of $1.379 billion the same period last year.

Posted In: PTVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist